Startseite
Podcasts
BiocompCHATibility Podcast
When to Go with In Vitro: Your Irritation Questions Answered

When to Go with In Vitro: Your Irritation Questions Answered

BiocompCHATibility vor 5 Jahren

0:00

35:50

Podcast

BiocompCHATibility

38 Episoden

A podcast dedicated to medical device biocompatibility

Wissenschaft Gesundheit & Fitness

Podcast aneignen

In this episode, our hosts answer listener questions regarding
the new ISO 10993-23:2021 from NAMSA’s February 3, 2021 webinar.

The standard recommends that In Vitro testing be completed prior
to In Vivo testing, warranting many questions about how to deal
with legacy data, regulatory acceptance and timelines. Our hosts
will provide podcasters a full episode of responses, possible
scenarios and potential recommendations.

“This is an extraction-based evaluation and you will be creating
and dosing extracts in most cases. There is not a direct contact
equivalent for the In Vitro like there is In Vivo.” Don Pohl

“In the past, you used the intracutaneous or primary skin
appropriately, then this In Vitro test is for you.” Don Pohl

“We have heard from one Notified Body that they are going to be
giving a one-year grace period, [meaning the standard just issued
in January 2021], they are giving folks until January 2022 to
switch to the In Vitro method.” Sheri Krajewski-Bibins

“Similar concept to Part 1, if you already have your data
collected, it might be worth mentioning in your biological
evaluation report. If you feel like you need to [mention]
regarding the timing of events, that testing was already planned,
executed and performed prior to -23 issuing, therefore, the In
Vivo method was utilized.” Don Pohl

“If you are having a pre-sub with the FDA, maybe have that
conversation too that you would like to do the In Vitro method,
and see what they tell you even though there is no official
position.” Sheri Krajewski-Bibins

“The standard has the one sentence that says In Vivo may be
needed post In Vitro to clarify, but it doesn’t necessarily say
because you failed or found an irritant….. I think you need to
still be careful on your due diligence. Look at your failure in
the In Vitro level, understand the materials, your manufacturing
process, and confirm you didn’t miss anything.” Don Pohl

Discussion points include:

What is in the new 10993-23 and what is it not?

How do you know if an In Vitro irritation test is right for
an implant?

Regulatory agency answers on when they will expect In Vitro
irritation

Limitations of the In Vitro assay

What to do if you receive an irritant response in the In
Vitro assay